Rebecca Jordan Bristol Myers Squibb

Rebecca Jordan is the US-based PDA Interest Group lead for ATMPs. She also serves as Director, Global Sterility Assurance Lead for the BMS Cell Therapy Franchise. She oversees all things contamination control in manufacturing facilities spanning across the Globe. Rebecca has over 16 years’ experience in industry, with the past 7 in the Cell Therapy space. She has supported both large and small manufacturing sites, new facility design and start-up, and global regulatory interactions. She has experience with a diverse product portfolio spanning everything from phase I INDs, veterinary, controlled substance, to commercial approvals of parenteral and CAR T medicines. She is a skilled investigator with a curious mind which has led to engaging diverse endeavors throughout her career. Rebecca holds a B.S. in Biology from Fitchburg State University.